摘要
目的探讨伊马替尼治疗胃肠道间质瘤的疗效。方法对长海医院2007年1月～2009年9月收治的58例经伊马替尼治疗的胃肠道间质瘤病人的临床资料进行回顾性分析。结果局限可切除胃肠道间质瘤患者36例,无一例复发或转移。22例广泛期胃肠道间质瘤患者中,服药3个月CT评价:完全缓解0例(0%),部分缓解11例(50%),稳定11例(50%),进展0例(0%),临床获益率100%;1年生存率为95.5%。结论伊马替尼治疗局限期和广泛期胃肠道间质瘤都具有较好的临床获益。
Objective To investigate the effects of imatinib on gastrointestinal stromal tumor. Methods From January 2007 to September 2009, 58 Imatinib - treated patients with gastrointestinal stromal tumors were analyzed retrospectively. Results In 36 eases in local stage, no recurrence or metastasis was found. After Imatinib being used for 3 months, outcome of patients in extensive stage were CR 0, PR 50% , SD 50% and PD 0. The 1 - year overall survival rate was 100%. Conclusion Imatinib is effective for gastrointestinal stromal tumors both in local stage and extensive stage.
出处
《医学研究杂志》
2010年第9期94-96,共3页
Journal of Medical Research
关键词
胃肠间质瘤
伊马替尼
治疗
Gastrointestinal stromal tumor
Imatinib
Treatment
